IRCT20220529055013N1
Not Yet Recruiting
Phase 4
Efficacy of Dapagliflozin in diabetic and nondiabetic patients with Acute heart failure
Public Sector medical University0 sites160 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Public Sector medical University
- Enrollment
- 160
- Status
- Not Yet Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Male/Female patients 30 years and above
- •2\. Diagnosis of acute decompensated heart failure made on admission based on any two of the following signs and symptoms a)Dyspnea at rest or minimal exertion b)Peripheral edema c) Ascites d)5\-pound weight gain (rapid) e) Signs of congestion on X\-ray
- •3\. Left ventricular Ejection fraction \= 40%
- •4\. eGFR \= 30ml/min
Exclusion Criteria
- •Cardiogenic shock;
- •urgent hospitalization for acute heart failure primarily triggered by pulmonary embolism ,cerebrovascular accident, or acute myocardial infarction
- •Current hospitalization for acute heart failure not caused primarily by intravascular volume overload
- •Type 1 Diabetes mellitus
- •History of Diabetic ketoacidosis
- •History of hepatic impairment
- •Known allergy to SGLT 2 inhibitors
- •Women pregnant or breast feeding
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
The potential effect of Dapagliflozin on diabetic macular edemadiabetic macular edema, diabetesJPRN-UMIN000020331Kyoto Prefectural University of Medicine Department of Endocrinology and Metabolism45
Not Yet Recruiting
N/A
Effect of Dapagliflozin for type 2 diabetes mellitus with fatty liverJPRN-UMIN000026549Kagawa prefectural central hospital25
Completed
N/A
Effect of Dapagliflozin in patients with type 2 daibetes mellitusType 2 diabetes mellitusJPRN-UMIN000014922Iwasaki Naika Clinic50
Not Yet Recruiting
Phase 4
Assessment of Empagliflozin effects in coronary artery diseaseIRCT20190412043247N2Zanjan University of Medical Sciences100
Recruiting
Phase 2
A single-site study of the effectiveness of Dapagliflozin for diabetic patients admitted to the intensive care unitDiabetesMetabolic and Endocrine - DiabetesACTRN12621001102864Austin Health40